DGCA issues guidelines for carrying vaccine in passenger aircraft

Dry ice, which is used to pack the vaccine, transforms into carbon dioxide gas at temperatures higher than -78 degrees Celsius and is therefore classified as "dangerous goods" by ICAO

Covid-19 vaccine
A medic worker arranges ice bags during a dry run for the COVID-19 vaccination, at Victoria hospital in Jabalpur on Friday.
Arindam Majumder New Delhi
2 min read Last Updated : Jan 08 2021 | 8:31 PM IST
Aviation regulator DGCA on Friday issued guidelines to all aircraft operators that plan to transport Covid-19 vaccines packed in dry ice to various parts of the country. Dry ice transforms into carbon dioxide gas at temperatures higher than -78 degrees Celsius under normal atmospheric pressure and therefore it is classified as ”dangerous goods” by the International Civil Aviation Organization (ICAO), it said.


 
”All operators while engaging in the transportation of Covid-19 vaccines packed with dry ice shall establish the maximum quantity of dry ice that can be loaded in a given cargo hold or in the main deck (passenger cabin) when a passenger version is deployed for all-cargo operations,” the Directorate General of Civil Aviation (DGCA) noted. The country is preparing for the roll-out of Covid-19 vaccines and the second nationwide mock drill on the drive was conducted on January 8.

India’s drugs regulator has approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

India’s drugs regulator has approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :DGCACoronavirus Vaccinepassenger aircraftSerum Institute of IndiaBharat Biotech

Next Story